» Articles » PMID: 17673144

Diammonium Glycyrrhizinate, a Component of Traditional Chinese Medicine Gan-Cao, Prevents Murine T-cell-mediated Fulminant Hepatitis in IL-10- and IL-6-dependent Manners

Overview
Date 2007 Aug 4
PMID 17673144
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Diammonium glycyrrhizinate (DG), a traditional Chinese medicine (TCM), is extracted and purified from liquorices (Radix glycyrrhizae). The liquorices exert an important function in the treatment of hepatitis because of its anti-inflammatory effects based upon the clinical practice, but the underlying mechanism is unclear. In this study, we investigated the mechanisms of DG in protecting mice from ConA-induced hepatitis. The results showed that intraperitoneal administration of DG protected mice against ConA-induced elevation of serum ALT levels and apoptosis of hepatocytes; at the same time, the absolute amount of hepatic NKT cells and T cells was significantly decreased, indicating that DG can inhibit the recruitment of lymphocytes into the liver. In addition, the production of IL-6 and IL-10 was improved by DG pretreatment, suggesting that DG may possibly protect the liver from injury via two pathways: direct protection of hepatocytes from apoptosis through an IL-6-dependent way and indirect inhibition of T-cell-mediated inflammation through an IL-10-dependent way.

Citing Articles

Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions.

Yu Y, Wang S, Liu Z, Zhang X, Hu Z, Dong H Chin Med. 2023; 18(1):59.

PMID: 37210537 PMC: 10199665. DOI: 10.1186/s13020-023-00751-7.


Diammonium glycyrrhizinate lipid ligand ameliorates lipopolysaccharide-induced acute lung injury by modulating vascular endothelial barrier function.

Liu M, Zhou J, Ji D, Yang J, Huang Y, Wang Q Exp Ther Med. 2021; 21(4):303.

PMID: 33717246 PMC: 7885082. DOI: 10.3892/etm.2021.9734.


The renoprotective effect of glycyrrhizic acid in insulin-resistant rats exposed to aluminum involves the inhibition of TLR4/NF-κB signaling pathway.

Emara N, Mahmoud M, El Fayoumi H, Mahmoud A Naunyn Schmiedebergs Arch Pharmacol. 2020; 394(5):863-872.

PMID: 33165681 DOI: 10.1007/s00210-020-02012-y.


Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches.

Kalhor H, Sadeghi S, Abolhasani H, Kalhor R, Rahimi H J Biomol Struct Dyn. 2020; 40(3):1299-1315.

PMID: 32969333 PMC: 7576931. DOI: 10.1080/07391102.2020.1824816.


Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients.

Ding H, Deng W, Ding L, Ye X, Yin S, Huang W J Med Virol. 2020; 92(10):2200-2204.

PMID: 32458502 PMC: 7283756. DOI: 10.1002/jmv.26064.